DW 2143
Alternative Names: DW-2143Latest Information Update: 07 Feb 2008
Price :
$50 *
At a glance
- Originator Dong Wha
- Developer Dong Wha Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 10 Oct 1998 Preclinical development for Cancer in Japan (Unknown route)